Literature DB >> 16484445

Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology.

S-M A Kulmala1, S M Syrjänen, U B Gyllensten, I P Shabalova, N Petrovichev, P Tosi, K J Syrjänen, B C Johansson.   

Abstract

BACKGROUND: Integration of human papillomavirus (HPV) DNA has been considered a late event in cervical carcinogenesis. However, integrated forms of HPV were recently detected in cancer precursor lesions using a new real time polymerase chain reaction (PCR) to detect the deletions at the 3362-3443 region of HPV16 E2
OBJECTIVE: To study the frequency of HPV16 DNA integration in cervical lesions and compare the sensitivity of an additional upstream region of the E2 ORF (2962-3138) in detecting HPV integration.
METHODS: Using the TaqMan based PCR, HPV16 positive DNA samples were analysed in 164 cervical scrapings from women participating in a multicentre screening trial. Biopsy confirmation was available in 62 cases.
RESULTS: Primers targeting the 3362-3443 region detected the majority of E2 deletions. In only 23% of the samples was the E2 upstream region equal or better target than the 3362-3443 region. Mixed (episomal/integrated) pattern was the most prevalent physical state of HPV16, also present in PAP smears with normal morphology. Pure integrated form was most prevalent in HSIL and cancer lesions, but also detectable in low grade abnormalities (NSIL, ASC-US, LSIL). Women with only integrated HPV16 were almost 10 years older than those with episomal HPV16. Viral load of integrated HPV16 was related to cytological abnormality (p = 0.003) but not to histology.
CONCLUSIONS: Integrated HPV16 is present in low grade cervical lesions, mostly mixed with the episomal form. Women with the pure integrated form of HPV16 are older than those with the other forms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16484445      PMCID: PMC1860285          DOI: 10.1136/jcp.2004.024570

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  43 in total

1.  Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16.

Authors:  William Alazawi; Mark Pett; Barbara Arch; Laurie Scott; Tom Freeman; Margaret A Stanley; Nicholas Coleman
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

2.  Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR.

Authors:  Shoji Nagao; Mitsuo Yoshinouchi; Yasunari Miyagi; Atsushi Hongo; Junichi Kodama; Sachio Itoh; Takafumi Kudo
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity.

Authors:  Patrick K Ha; Sara I Pai; William H Westra; Maura L Gillison; Betty C Tong; David Sidransky; Joseph A Califano
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

4.  Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions.

Authors:  C Clavel; M Masure; M Levert; I Putaud; C Mangeonjean; M Lorenzato; P Nazeyrollas; R Gabriel; C Quereux; P Birembaut
Journal:  Diagn Mol Pathol       Date:  2000-09

5.  Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study.

Authors:  A M Josefsson; P K Magnusson; N Ylitalo; P Sørensen; P Qwarforth-Tubbin; P K Andersen; M Melbye; H O Adami; U B Gyllensten
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

6.  Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance.

Authors:  Mark van Duin; Peter J F Snijders; Henri F J Schrijnemakers; Feja J Voorhorst; Lawrence Rozendaal; Marielle A E Nobbenhuis; Adriaan J C van den Brule; René H M Verheijen; Theo J Helmerhorst; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2002-04-01       Impact factor: 7.396

7.  Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.

Authors:  D C Swan; R A Tucker; G Tortolero-Luna; M F Mitchell; L Wideroff; E R Unger; R A Nisenbaum; W C Reeves; J P Icenogle
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

8.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells.

Authors:  S Jeon; B L Allen-Hoffmann; P F Lambert
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Viral load of human papillomavirus and risk of CIN3 or cervical cancer.

Authors:  Attila T Lorincz; Philip E Castle; Mark E Sherman; David R Scott; Andrew G Glass; Sholom Wacholder; Brenda B Rush; Patti E Gravitt; John E Schussler; Mark Schiffman
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

10.  Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women.

Authors:  Dulce M Hernández-Hernández; Laura Ornelas-Bernal; Miriam Guido-Jiménez; Teresa Apresa-Garcia; Isabel Alvarado-Cabrero; Mauricio Salcedo-Vargas; Alejandro Mohar-Betancourt; Alejandro Garcia-Carranca
Journal:  Gynecol Oncol       Date:  2003-08       Impact factor: 5.482

View more
  36 in total

1.  HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections.

Authors:  Anna Manawapat-Klopfer; Lisa Wang; Juliane Haedicke-Jarboui; Frank Stubenrauch; Christian Munk; Louise T Thomsen; Peter Martus; Susanne K Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  Physical state and viral load as predictive biomarkersfor persistence and progression of HPV16-positive cervical lesions: results from a population based long-term prospective cohort study.

Authors:  Anna Manawapat; Frank Stubenrauch; Rainer Russ; Christian Munk; Susanne Kruger Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2012-02-15       Impact factor: 6.166

3.  Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia.

Authors:  Mina Kalantari; Kathryn Osann; Itzel E Calleja-Macias; Seong Kim; Bing Yan; Sara Jordan; Dana M Chase; Krishnansu S Tewari; Hans-Ulrich Bernard
Journal:  Virology       Date:  2013-11-09       Impact factor: 3.616

4.  HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.

Authors:  Dorota Pastuszak-Lewandoska; Anna Bartosińska-Dyc; Monika Migdalska-Sęk; Karolina H Czarnecka; Ewa Nawrot; Daria Domańska; Krzysztof Szyłło; Ewa Brzeziańska
Journal:  Med Oncol       Date:  2014-01-17       Impact factor: 3.064

5.  Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women.

Authors:  Agnihotram V Ramanakumar; Otelinda Goncalves; Harriet Richardson; Pierre Tellier; Alex Ferenczy; François Coutlée; Eduardo L Franco
Journal:  BMC Infect Dis       Date:  2010-11-11       Impact factor: 3.090

6.  Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer.

Authors:  Jo L K Cheung; T H Cheung; Julian W T Tang; Paul K S Chan
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

7.  Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.

Authors:  Elise Jacquin; Alice Baraquin; Rajeev Ramanah; Xavier Carcopino; Adrien Morel; Séverine Valmary-Degano; Ignacio G Bravo; Silvia de Sanjosé; Didier Riethmuller; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

8.  The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.

Authors:  Wei Li; Wei Wang; Mani Si; Linfei Han; Qinglei Gao; Aiyue Luo; Yan Li; Yunping Lu; Shixuan Wang; Ding Ma
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-14       Impact factor: 4.553

9.  Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma.

Authors:  Maëlle Saunier; Sylvain Monnier-Benoit; Frédéric Mauny; Véronique Dalstein; Jenny Briolat; Didier Riethmuller; Bernadette Kantelip; Elisabeth Schwarz; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

10.  Genomic instability of the host cell induced by the human papillomavirus replication machinery.

Authors:  Meelis Kadaja; Alina Sumerina; Tatjana Verst; Mari Ojarand; Ene Ustav; Mart Ustav
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.